Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
An Open label, Phase I/II study to evaluate the safety and efficacy of Tenalisib RP6530, a novel PI3K ?/? dual inhibitor given in combination with a histone deacetylase HDAC inhibitor, Romidepsin in adult patients with relapsed/refractory T-cell Lymphoma
A Phase I, Multicenter, Open-Label, Dose Escalation and Dose Expansion Study of SQZ-PBMC-HPV as Monotherapy and in Combination with Atezolizumab in HLA-A02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
Phase I/II Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells VCAR33 in Patients with Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
Study Type: Treatment
Phase: I/II
NCTID: NCT05984199
Principal Investigator:
Muhammad Umair Mushtaq
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage II Colon Cancer
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes ypN1mi, ypN1-3 After Neoadjuvant Chemotherapy
Phase III Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination with Cetuximab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor.
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas PAZNTIS: A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minues Pazopanib NSC 737754, IND 118613
Study Type: Treatment
Phase: II/III
NCTID: NCT02180867
Principal Investigator:
A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor MUD versus HLA-Haploidentical Related Haplo Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults AYA with Acute Leukemia or Myelodysplastic Syndrome MDS
Study Type: Treatment
Phase: III
NCTID: NCT05457556
Principal Investigator:
Ibrahim Ahmed
Phase II Study in Patients With Resected, Stage II High Risk and Stage III Colorectal Cancer
Pediatric Acute Leukemia PedAL Screening Trial - Developing New Therapies for Relapsed Leukemias
Study Type: Screening
Phase: N/A
NCTID: NCT04726241
Principal Investigator:
Kevin Ginn